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Abstract
Background: Methionine sulfoxide reductases (Msrs) are repair enzymes that protect proteins from oxidative stress by
catalyzing stereospecific reduction of oxidized methionine residues. MsrB1 is a selenocysteine-containing cytosolic/nuclear
Msr with high expression in liver and kidney.
Principal Findings: Here, we identified differences in MsrB1 gene structure among mammals. Human MsrB1 gene consists
of four, whereas the corresponding mouse gene of five exons, due to occurrence of an additional intron that flanks the stop
signal and covers a large part of the 39-UTR. This intron evolved in a subset of rodents through intronization of exonic
sequences, whereas the human gene structure represents the ancestral form. In mice, both splice forms were detected in
liver, kidney, brain and heart with the five-exon form being the major form. We found that both mRNA forms were
translated and supported efficient selenocysteine insertion into MsrB1. In addition, MsrB1 occurs in two protein forms that
migrate as 14 and 5 kDa proteins. We found that each mRNA splice form generated both protein forms. The abundance of
the 5 kDa form was not influenced by protease inhibitors, replacement of selenocysteine in the active site or mutation of
amino acids in the cleavage site. However, mutation of cysteines that coordinate a structural zinc decreased the levels of 5
and 14 kDa forms, suggesting importance of protein structure for biosynthesis and/stability of these forms.
Conclusions: This study characterized unexpected diversity of protein and mRNA forms of mammalian selenoprotein MsrB1.
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Introduction
Oxidation of proteins during aging or under conditions of
oxidative stress may lead to alterations in protein structure and
function and has been linked to age-related diseases [1,2].
Methionine sulfoxide reductases (Msrs) are repair enzymes, which
reduce oxidized methionine residues in proteins in a stereospecific
manner. Two such protein families are known, including MsrA
and MsrB that act on methionine S-sulfoxide (Met-SO) and
methionine R-sulfoxide (Met-RO), respectively. Mammals contain
three MsrB isozymes localized to different cell compartments. One
of them is MsrB1 (previously known as SelR or SelX) that localizes
to the nucleus and cytosol. It is a selenoprotein that contains
selenocysteine (Sec) in place of cysteine normally present in the
catalytic sites of MsrBs and MsrAs [3].
The role of MsrA in protecting cells against oxidative stress has
been well documented in bacteria, yeasts, plants and mammals
[4,5,6,7,8,9,10,11]. There are also many reports of this function
for MsrB [9,11,12,13,14,15,16]. Under certain conditions, over-
expression of MsrB can increase lifespan in yeast [12]. Overex-
pression of MsrB2 protects MOLT-4 cells against oxidative stress
[9,14]. The enzymatic activities of MsrA and MsrB were
significantly lower in the organs of aged animals [11]. Our
previous studies showed increased levels of malondialdehyde,
protein carbonyls, protein methionine sulfoxide, and oxidized
glutathione in liver and kidney of MsrB1 knockout mice [13]. In
addition, two protein forms (14 and 5 kDa) of MsrB1 were
detected in mouse tissues. Mass spectrometry analysis of the 5 kDa
protein suggested that this short form corresponds to the C-
terminal fragment of MsrB1 starting with Asn76 [13]. However,
the mechanism of formation and biological functions of this form
are not known.
In the present study, we analyzed recombinant mouse MsrB1
and its Sec-to-Cys mutant protein expressed in HEK 293 cells and
E. coli. Our research suggests that the 5 kDa form was not
produced due to alternative translation initiation and does not
require Sec insertion, but that its levels are regulated by the
stability of MsrB1 structure.
The 39-untranslated regions (UTRs) often contain regulatory
elements that govern spatial and temporal properties of mRNAs,
including mRNA stability, localization and translation [17]. About
half of mammalian genes use alternative polyadenylation to
generate multiple mRNA isoforms [18,19,20]. Our analysis of
MsrB1 cDNA sequences revealed two forms of the 39-UTR in
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differences in gene structure between rodents and most other
mammals, including humans, due to the process of intronization
wherein exonic sequences were recruited to generate a new intron
within the 39-UTR. We report characterization of these mRNA
and protein forms of MsrB1.
Materials and Methods
Computational analyses of MsrB1 sequences
Sec-containing MsrB1 sequences were collected using
TBLASTN. Mouse MsrB1 protein sequence was used as a query
sequence to search against NCBI EST database. Sequences
containing Sec encoded by TGA codon were analyzed for
occurrence of SECIS elements using SECISearch. EST sequences
with predicted SECIS elements were searched against NCBI
genome and non-redundant nucleotide databases to assess
genomic sequences and against NCBI EST database to examine
splicing and alternative splicing events. All selected sequences were
analyzed for splice donor and acceptor sites with NetGene2
Server. Only Mus musculus and Rattus norvegicus genomic DNA
possessed reliable splice sites within the 39-UTR. MsrB1 structure
was modeled with Modeler 8.2.
Quantification of MsrB1 mRNA expression in C57BL/6
mice
Total RNA was extracted from previously frozen various tissues
of two C57BL/6 mice with RNAqueousHKit (Applied Biosystems/
Ambion, Austin, TX). Purified RNA samples (1 mg) were treated
with RNAse-free DNAse (Fermentas), and then used to synthesize
cDNA using M-MulV reverse transcriptase and Oligo dT primers
(Fermentas) according to manufacturer’s instructions. The primers
for the analysis for MsrB1 mRNA expression were designed by
GenScript Real Time Primer Design Program and they are as
follows: forward, 59-CTTCGGAGGCGAGGTTTTCC-39, and
reverse, 59-TCTCAGGGCACTTGGTCACA-39, which produce
a 164 bp amplicon corresponding to the MsrB1 coding region
between exons 1 and 2. Primers specific for the MsrB1 Form 2:
forward, 59-TGGAAGGTTTCCACTGCTCT-39, and reverse,
59- AAGGAGATTGGTGGCAGTTT -39, generate a 126 bp
amplicon. GAPDH expression was used as control and the primers
were 59-TCACCACCATGGAGAAGGC-39 (forward) and 59-
GCTAAGCAGTTGGTGGTGCA-39 (reverse) [21]. The PCR
amplification mixture (25 ml) contained 25 ng template cDNA,
12.5 ml 2X SYBR green I master mix buffer (Bio-Rad), and
300 nM forward and reverse primers. Each assay (in triplicate)
included a non-template control and a non-RT control. Reactions
were run on a MyiQ real-time PCR detection system (Bio-Rad).
Gene expression was analyzed by Gene Expression Macro (Bio-
Rad) and PCR products were also analyzed by 2% agarose gel
electrophoresis to confirm product size and specificity.
Cloning, expression, purification, detection of
recombinant mouse MsrB1
To express MsrB1 in mammalian cells, the following constructs
were generated: wild-type and cysteine (Cys) mutant cDNA of
mouse MsrB1 (NM_013759) corresponding to Form 1 39-UTR
were amplified from pET28a (+) MsrB1-Sec and pET28a (+)
MsrB1-Cys as templates that were previously constructed in the
laboratory. The cDNA for MsrB1 corresponding to Form 2 39-
UTR was amplified from a mouse EST clone (IMAGE: 6432555,
Open Biosystems, Huntsville, AL). The PCR products were
sequence verified and cloned into Xho1/EcoR1 sites of pEGFP-
C3 to generate constructs coding for proteins with N-terminal
GFP tags. The resulting constructs were named as pEGFP-MsrB1-
F1 (with Form 1 39-UTR), pEGFP-MsrB1-U95C (with Form 1 39-
UTR), and pEGPC3-MsrB1-F2 (with Form 2 39-UTR). All other
mutant forms of MsrB1 were generated by site-directed mutagen-
esis using Stratagene’s QuickChange site-directed mutagenesis kit
and pEGFP-MsrB1-F1 as a parent DNA.
To express wild-type and mutant forms of GFP-tagged MsrB1
in HEK 293 cells, constructs were transfected into cells using a
calcium phosphate method. The transfected cells were cultured in
DMEM medium supplemented with 10% newborn bovine serum
for 48 h at 37uC in the atmosphere of 5% CO2. To extract the
protein, cell pellets were lysed with mammalian cell lysis reagent
(Sigma) containing complete protease inhibitor mixture (Roche)
for 15 min at room temperature, cell lysates were spun down for
10 min at 4uC, and 30 mg of soluble protein was resolved by SDS-
PAGE and transferred onto polyvinylidene difluoride membranes.
MsrB1 was detected by immunoblot assays with polyclonal
antibodies against mouse MsrB1 or visualized by PhosphorImager
if cells were metabolically labeled with
75Se.
The construct pET28a(+) MsrB1-Cys, described previously [22]
was used for expression of MsrB1-Cys mutant containing an N-
terminal His-tag in E. coli BL21 (DE3). Based on the above
construct, a factor Xa cleavage site (IEGR) was inserted into the
MsrB1 coding region between Gly75 and Asn76, a previously
predicted cleavage site in MsrB1 [13]. Recombinant proteins were
expressed in E. coli by inducing protein expression in log phase
cultures with 0.2 mM isopropyl-D-1-thiogalactopyranoside
(IPTG) at 30uC for 4 h, and proteins were purified using cobalt-
conjugated affinity resins (TALON Metal Affinity Resin, Clon-
tech, Mountain View, CA) according to the manufacturer’s
instructions.
Metabolic labeling of cells with
75Se
[
75Se]-Selenite (specific activity 1,000 Ci/mmol) was obtained
from the Research Reactor Facility, University of Missouri
(Columbia, MO). HEK 293 cells transfected with the constructs
were maintained for 24 h and then metabolically labeled with
75Se
for 16–24 h as described [23]. Extracts from these cells were
subjected to SDS-PAGE, proteins were transferred onto poly-
vinylidene difluoride membranes, and selenoproteins were detect-
ed with a PhosphorImager.
MsrB activity assays
MsrB1 activity was measured using DTT as a reductant. 100 ml
reaction mixtures contained 20 mM DTT, 200 mM dabsyl-Met-
RO, and 0.5–20 mg protein in PBS. The reaction was carried out
at 37uC for 30 min and products were analyzed by an HPLC
method as described previously [24].
Extraction of proteins from mouse tissues
Mouse tissues were homogenized on ice in PBS, pH 7.4,
containing complete protease inhibitor, EDTA and PMSF,
centrifuged and the supernatants were used for activity and
immunoblot assays.
Results
Identification of two forms of mouse MsrB1 mRNA
Computational analysis of mammalian MsrB1 ESTs revealed
two cDNA forms in mice that differed in the 39-UTR. One cDNA
form, further designated as Form 1, had 462 bp in its 39-UTR,
and the other, Form 2, 834 bp. The two forms yielded identical
predicted ORFs. Compared to Form 1, Form 2 had an extra 372
nucleotides at the 59 end of the 39-UTR. Aligning these two
Diversity of MsrB1 Forms
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the presence of an extra intron (intron 4), located immediately
following the stop codon, i.e., Form 1 lacked a larger part of the
39-UTR that was present in Form 2 (Fig. 1A).
Rodent-specific intronization to generate two mRNA
forms
Searches for homologs of mouse Forms 1 and 2 in NCBI
dbEST database found matches to rat (Rattus norvegicus), guinea pig
(Cavia porcellus), platypus (Ornithorhynchus anatinus), and human (Homo
sapiens) sequences. Interestingly, all rat sequences corresponded to
mouse Form 1 MsrB1 cDNA, whereas all other organisms were
represented by Form 2 sequences (Fig. 1B). Further analysis
revealed a splice donor site immediately following the stop codon
and a splice acceptor site about 400 nucleotides downstream in
mouse and rat sequences, whereas these sites were ambiguous or
undetectable in other organisms (Fig. 1C). Thus, there were two
alternative mRNA forms of MsrB1 in mammals, but both of these
forms were only present in mice. Other mammals had single
forms, either Form 1 or Form 2. The ancestral form was
apparently Form 2 because it was present in diverse mammals,
whereas Form 1 was in a small subset of closely related rodents.
Thus, in some rodents (i.e., mice and rats, but not guinea pigs), an
additional intron evolved within the 39-UTR through the process
known as intronization, i.e., recruitment of exonic sequences to
generate an intron. Interestingly, this intron did not include the
SECIS element, which is essential for Sec insertion into MsrB1
and located in the region of the 39-UTR that was shared by Form
1 and Form 2.
Alternative splicing in mouse MsrB1
As mentioned in the previous section, mouse was the only
mammal detected to possess two forms, wherein it occupied an
intermediate position between human and other non-rodent
mammals (Form 2) on one hand and rat (Form 1) on the other.
To further examine the significance of alternative splicing in
mouse MsrB1 39-UTR, we analyzed the occurrence and
distribution of Form 1 and Form 2 ESTs in dbEST database.
127 mouse ESTs were detected, including 30 Form 2 and 13 Form
1 sequences (other sequences did not cover the region containing
alternative sequences). Form 1 was enriched in C57BL/6 mice (6
out of 13), and Form 2 in FVB mice (5/17), mammary gland (5/
17) and tumors (7/17). There were two FVB cDNA libraries that
contained both forms. Overall, it appears that intron 4 is
alternatively spliced in mice in a process that is partially influenced
by mouse strain and disease state.
Characterization of MsrB1 mRNA forms in mice
To directly examine expression of MsrB1 mRNA forms in mice,
we analyzed their expression levels in liver, kidney, brain, and
heart in two C57BL/6 mice by real-time PCR. Both forms were
detected in all mouse tissues examined. Form 2 was 7–25% of the
total MsrB1 mRNA (Fig. 2B, C), indicating that Form 1 was the
major form. We also amplified the full length MsrB1 cDNA from
mouse liver and sequencing revealed Form 1 sequence. Quanti-
tation of MsrB1 mRNA indicated that it ranked in the following
order: liver, kidney, heart, and brain. This is also consistent with
MsrB1 protein expression in these organs of mice as analyzed by
Western blot assays (data not shown).
Both mRNA forms of mouse MsrB1 support
selenoprotein synthesis and efficient Sec insertion
To test if the two mRNA forms generate functional MsrB1, we
prepared the corresponding expression constructs differing in the
39-UTR and coding for an N-terminal GFP followed by mouse
MsrB1 sequences. These constructs were transfected into HEK
293 cells, which were then metabolically labeled with
75Se. Both
MsB1 mRNA forms generated a full-length GFP-MsrB1, which
was labeled with
75Se at the same level (Fig. 3A) and generated
similar amounts of protein (P.0.05) (Fig. 3B, C). MsrB1 was the
major selenoprotein in transfected cells, indicating highly efficient
Sec insertion by the MsrB1 SECIS element. Thus, both mRNA
Figure 1. Alternative splice forms of MsrB1. (A) Genomic structure of mouse MsrB1. Red boxes indicate exons corresponding to the coding
region, blue boxes show 39-UTRs, and yellow boxes show the SECIS element. Top panel shows the Form 1 MsrB1 mRNA which lacked intron 4 due to
the process of intronization. Bottom panel represents the ancestral form, Form 2 MsrB1 mRNA. (B) Schematic representation of 39-UTRs of mammalian
MsrB1 sequences. The stop codon is shown in orange, 39-UTRs in green, alternatively spliced regions in blue, and SECIS elements in yellow. (C) Splice
donor and acceptor sites in the 39-UTR of MsrB1. The stop codon is shown in red. Intron-exon junctions are indicated by ‘‘‘’’.
doi:10.1371/journal.pone.0011497.g001
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comparison, we expressed a Cys mutant of MsrB1 in HEK 293
cells. As expected, it was expressed at higher levels than the Sec-
containing form (P,0.01) (Fig 3B, C) (because Sec insertion is
slower than Cys insertion), but was not labeled with
75Se (Fig. 3A).
Relationship between mRNA and protein forms of MsrB1
In addition to the two mRNA forms, MsrB1 protein occurs in
two protein forms that migrate as 14 and 5 kDa proteins. We
tested which of the two mRNA forms gives rise to different protein
forms (Fig. 3A) and found that expression of GFP-MsrB1 fusion
protein from either mRNA form led to the appearance of a short
5 kDa protein, which was labeled with
75Se to the same extent.
Thus, each mRNA form can lead to the synthesis of two protein
forms.
Sec is not required to generate the 5 kDa form
MsrB1 is a Sec-containing protein. To test if generation of the
short form requires Sec, we examined the production of the 5 kDa
form from wild-type MsrB1 and its Sec-to-Cys mutant expressed
in HEK 293 cells. The 5 kDa form was detected by western blot
analysis with antibodies against recombinant MsrB1 (Fig. 3B) and
it was present in cells expressing either Sec-containing or Cys-
containing MsrB1 forms. As expected, expression of both full-
length and 5 kDa forms was higher in the case of Cys mutant
because Sec insertion is slow in mammalian cells (Fig. 3C).
Roles of amino acids coordinating structural zinc
Immediately upstream of the candidate cleavage site, two Cys
residues are located that bind zinc (Fig. 4). These residues form a
CxxC motif. There is a second CxxC motif located further
upstream that is also involved in zinc coordination [24]. We
mutated Cys26 to Ala and also made a mutant that replaced
Cys74 and Gly75 with alanines. Each cysteine mutation led to a
reduced expression of both 5 and 14 kDa forms (Fig. 5D). As these
Cys are required for folding and correct structure of MsrB1, our
data implicated protein structure in regulation of MsrB stability
and/or maturation to generate the cleaved forms.
In a recent study, we suggested that the 5 kDa form is generated
by proteolytic cleavage of the 14 kDa form [13]. Since sample
preparation is a common cause of proteolytic cleavage, especially
in mammalian cells, we examined the production of the 5 kDa
form in HEK 293 cells expressing EGFP-MsrB1, wherein cells
were treated or not with complete protease inhibitor during cell
lysis or were subjected to direct denaturation by adding SDS-
PAGE sample buffer. However, metabolic
75Se labeling of samples
showed that there was no significant difference in the abundance
of the 5 kDa fragment among the samples (Fig. 5A). Thus, the
5 kDa form is not the result of sample preparation.
The 5 kDa form and alternative translation initiation
Alternative translation initiation is a common mechanism to
generate protein isoforms. We examined whether this process is
involved in the synthesis of the 5 kDa form. The MsrB1 ORF
lacks in-frame ATG codons, which could result in the production
of the 5 kDa form, but translation is also known to be initiated in
rare cases from other codons, most notable from XTG codons (X
is any nucleotide). Two such codons exist in MsrB1: TTG coding
for Leu78 and CTG coding for Leu83. We mutated these sites and
examined generation of the 5 kDa form. HEK 293 cells expressing
either mutant produced the 5 kDa form as detected by
PhosphorImager (Fig. 5B,C). These experiments excluded trans-
lation initiation as a possible mechanism to generate the 5 kDa
form.
Roles of amino acids in the candidate cleavage region
Mass-spectrometry analyses suggested that the 5 kDa form
could result from the cleavage between amino acids Gly75 and
Asn76 [13]. To test if these amino acid residues were necessary for
generation of the 5 kDa form, we mutated them to alanine
residues (Fig. 5B, C, D). Both mutants still produced the short
MsrB1 form when expressed in HEK 293 cells.
The 5 kDa fragment and MsrB1 activity
We examined if the cleavage that generates the 5 kDa fragment
affects MsrB1 activity. We cloned the predicted N-terminal (amino
acids 1–75) and C-terminal (amino acids 76–116) (Cys mutant was
used in this experiment because Sec insertion is an inefficient
process) segments of MsrB1 into pETDueT vector and expressed
them simultaneously in E. coli. However, neither fragment was
soluble. Since we did not know which protease is involved in the
cleavage of MsrB1, we engineered a cleavage site for factor Xa
protease by inserting the sequence coding for tetrapeptide IEGR
between Gly75 and Asn76 [13]. The resulting recombinant
Figure 2. Analysis of MsrB1 mRNA forms in mice. MsrB1 mRNA
expression in indicated organs of two C57BL/6 mice was analyzed by
real-time PCR. (A) Agarose gel electrophoresis analysis of MsrB1 PCR
products. Real-time PCR products derived from mouse MsrB1 mRNA
(Forms 1 and 2) and MsrB1 Form 2 mRNA were subjected to 2% agarose
gel electrophoresis. L, liver; K, kidney; H, heart; B, brain; M, molecular
markers, The size of the band running fastest is 100 bp, and that of the
adjacent band is 200 bp. (B) MsrB1 mRNA expression. Expression levels
of total MsrB1 mRNA (Forms 1 and 2) and Form 2 mRNA were
normalized to the levels of GAPDH mRNA, and the value for Form 2 in
the brain was set as 1. The data represent means6SD. (B) Relative
expression of MsrB1 Form 2 mRNA. Expression of MsrB1 Form 2 mRNA
was normalized to total MsrB1 mRNA.
doi:10.1371/journal.pone.0011497.g002
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treated with factor Xa, which cleaved the protein into fragments of
expected size (Fig. 6). We found that MsrB1 with the engineered
factor Xa cleavage site had some Msr activity, whereas treatment
with factor Xa protease in vitro resulted in the loss of this activity
(Table 1).
Oxidative stress and the 5 kDa fragment
Oxidative stress can lead to oxidation of methionine residues,
which are repaired by MsrB1. We examined a possibility that
oxidative stress triggers the cleavage of MsrB1, which in turn
regulates methionine sulfoxide reduction. HEK 293 cells express-
ing MsrB1 were treated with hydrogen peroxide and the
abundance of the 5 kDa form was examined by Western blot
analysis using antibodies specific for MsrB1 (Fig. 7). The data
suggested that the production of 5 kDa fragment did not change
after the treatment (P.0.05).
Lack of the 5 kDa fragment in MsrB2
Finally, we tested whether MsrB homologs may also generate
abundant cleavage forms by examining MsrB2 expression and
occurrence of full-length and shorter protein forms by immunoblot
assays in mouse tissues. Only the full-length form was detected in
liver, kidney, heart, and brain (Fig. 8). Thus, an abundant 5 kDa
fragment is not a common form of mammalian MsrBs.
Figure 3. Expression of mouse MsrB1 mRNAs. HEK 293 cells were transfected with the following constructs: pEGFP-MsrB1 Cys mutant (U95C),
pEGFP-MsrB1 with Form 1 39-UTR (Form 1) and pEGFP-MsrB1 with Form 2 39-UTR (Form 2). 24 h later, the cells were labeled with
75Se for an
additional 24 h. Protein extracts were prepared and resolved on SDS-PAGE gel, and selenoproteins were visualized with a PhosphorImager (A) or by
western blot analysis with MsrB1 antibodies (B, top panel). Coomassie Blue staining is shown as a loading control (B, lower panel). (C) Band intensities
corresponding to different forms of MsrB1 (B) were quantified with Image J. Protein expression levels were normalized to that of the U95C form.
Arrows indicate migration of a full-length EGFP-MsrB1 (42 kDa) and a short form (5 kDa) of MsrB1.
doi:10.1371/journal.pone.0011497.g003
Figure 4. Structural model of mouse MsrB1. The upper panel
shows a structural model of mouse MsrB1. Location of four cysteines in
two CxxC motifs and of Sec is indicated. The predicted cleavage site is
marked with a red dot and is highlighted by an arrow. Lower panel
shows mouse MsrB1 sequence. The two CxxC motifs are highlighted in
blue. The predicted cleavage site is also shown as ‘‘‘’’.
doi:10.1371/journal.pone.0011497.g004
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This study revealed an unexpected variety of mRNA and
protein forms in a small and relatively simple protein, MsrB1. This
finding adds a layer of complexity in regulation of this
selenoprotein. 39-UTRs play important roles in mRNA stability,
localization, and translation [25]. Eukaryotic selenoprotein
mRNAs, including the MsrB1 mRNA, have a stem loop structure,
designated SECIS element, located in the 39-UTR region, which is
required for Sec incorporation. A minimal distance between Sec
Figure 5. Analysis of the 5 kDa form. (A) Role of sample preparation in the generation of the 5 kDa form. HEK 293 cells were transfected with
pEGFP-MsrB1-F1 for 24 h, then labeled with
75Se for an additional 24 h. Cells were collected and lysed with sample buffer (Lane 3) or Sigma
mammalian cell lysis reagent in the presence (lane 2) or absence (lane 1) of protease inhibitors. Protein extracts were resolved on SDS-PAGE, and
selenoproteins were visualized with a PhosphorImager. (B-D) Roles of various amino acids in MsrB1 in generating the 5 kDa form. HEK 293 cells were
transfected with pEGFP-MsrB1-F1 or constructs containing mutations in one or two amino acids (as shown above lanes) for 24 h, then labeled with
75Se for an additional 24 h. Protein extracts were resolved on SDS-PAGE gels, and selenoproteins were visualized with a PhosphorImager (B, D) or by
western blot analysis with MsrB1 antibodies (C). The full-length EGFP-MsrB1 (42 kDa) and the short form (5 kDa) of MsrB1 are shown by arrows.
doi:10.1371/journal.pone.0011497.g005
Figure 6. Analysis of recombinant MsrB1. Top panel: Cys mutant
of MsrB1 (MsrB1-Cys) (lane 2) and its form with the engineered factor Xa
protease cleavage site (MsrB1-Cys-Xa) (lane 3) were analyzed by SDS-
PAGE followed by Coomassie Blue staining. MsrB1-Cys-Xa protein was
digested with factor Xa and the digestion products (lane 4) were
subjected to SDS-PAGE analysis. Molecular weight markers are shown in
lane 1. Arrows indicate migration of the uncleaved (full length) protein
and cleaved protein fragments (cleaved form). Bottom panel: Sequence
of MsrB1-Cys-Xa. The engineered factor Xa site is shown in blue, U95C
in orange, and the factor Xa cleavage site is shown by ‘‘‘’’.
doi:10.1371/journal.pone.0011497.g006
Table 1. Specific activity of mouse MsrB1-Cys and its mutant
forms.
Protein form Specific activity (nmol/min/mg protein)
MsrB1-Cys 1.560.1
MsrB1-Cys-Xa 3.360.1
Cleaved MsrB1-Cys-Xa ND
Catalytic activity of purified recombinant proteins was determined using
dabsyl-Met-RO as substrate. MsrB1-Cys: Cys mutant of mouse MsrB1, MsrB1-
Cys-Xa: Cys mutant of MsrB1 engineered to contain a factor Xa cleavage site
inserted in the coding region between Gly75 an Asn76. Cleaved MsrB1-Cys-Xa:
MsrB1-Cys-Xa cleaved with factor Xa. ND: not detected.
doi:10.1371/journal.pone.0011497.t001
Diversity of MsrB1 Forms
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[26]. An overall mRNA structure is also important for Sec
insertion [27]. In this regard, it is surprising that the new form of
mouse MsrB1 mRNA lacks a significant part of the 39-UTR, yet it
is as efficient in Sec insertion as the longer mRNA form.
Among 30 mouse MsrB1 ESTs, Form 1 sequences were
prevalent in samples from C57BL/6 mice, whereas Form 2
sequences were enriched in FVB mice. In addition, almost half of
Form 2 sequences were derived from tumors, whereas no tumors
gave rise to ESTs corresponding to Form 1 MsrB1 mRNA.
Consistent with the computational analysis, our experiment data
suggested that both Form 1 and Form 2 could be detected in
C57BL/6 mice, and that Form 1 was the major form. Aberrant
splicing is a common feature of cancer cells, and variation in
mRNA splicing of certain tumor-related genes has been identified
as a biomarker of certain tumors [28].
Computational analysis suggested that, in rats, only one (Form
1) MsrB1 mRNA was detected, whereas all other mammals
represented in dbEST possessed Form 2 mRNA. Thus, mouse
appeared to be the only mammal well represented in dbEST that
showed alternative splicing in MsrB1 mRNA, but it is likely that
future studies may find additional mammals with the two mRNA
forms.
Alternative splicing is an important mechanism for generating
functional and evolutionary diversity of proteins in eukaryotes, and
a recent study analyzed occurrence of rodent-specific exons. In
that study, separation of genes by the rate of sequence evolution
and by gene families has demonstrated that rodent-specific exons
are more frequent in rapidly evolving genes and in rodent-specific
paralogs [29]. This study is consistent with the idea that that gain
of alternative exons is one of the major mechanisms of gene
evolution.
Another study examined the possible mechanisms of spliceo-
somal intron creation in C. elegans and defined a process of
intronization, i.e., the recruitment of internal exonic sequences in
nematodes [30]. It appears that this process is as important as
several other mechanisms that lead to intron gain. Intronization
was more common than the reverse process, loss of splicing of
retained introns, in C. elegans. In fact, the process of intronization
was proposed to be the major mechanism that drives the evolution
of new exons and a major force in the shaping of gene structures
[31]. However, a recent study that examined Cryptococcus sequences
identified only five events of intron creation from internal exonic
regions by de novo emergence of new splicing boundaries, and no
cases of the reverse process, deintronization [32]. Although the
extent and mechanisms of intronization in mammals will require
further studies, our analysis clearly shows that the evolution of two
mRNA forms in mammalian MsrB1 is due to intronization of
exonic sequences specifically in a subset of rodents. In this regard,
MsrB1 may be a model case of intronization in mammals, where
this mechanism has not been yet studied in detail.
Our previous study also revealed two protein forms (14 kDa and
5 kDa) of MsrB1 in mouse tissues and human cell lines. Both
forms could be detected by
75Se labeling and western blotting with
polyclonal MsrB1 antibodies. To provide further evidence that the
5 kDa form corresponds to the C-terminal fragment of MsrB1
containing Sec95, we compared
75Se labeling patterns of HEK
293 cells expressing wild-type and Cys mutant of MsrB1. It was
clear that the 5 kDa form could only be detected in the case of
wild-type MsrB1 (Fig. 3B).
To gain insights into the mechanism of generation of the MsrB1
short form, we examined the correlation between its occurrence
and the following possible causes: sample preparation, alternative
translation initiation, and Sec presence in the protein. However,
Figure 7. Role of oxidative stress in generating the 5 kDa form. HEK 293 cells were transfected with pEGFP vector alone (vector) or pEGFP-
MsrB1-F1 wild-type (WT) for 24 h and then cultured with DMEM containing indicated concentrations of hydrogen peroxide for another 24 h. Protein
extracts were resolved on SDS-PAGE and detected by western blot analysis using antibodies specific for MsrB1 (A). MsrB1 band intensities were
determined with Image J and MsrB1 short form levels were normalized to those of the EGFP-MsrB1 form (B).
doi:10.1371/journal.pone.0011497.g007
Figure 8. Immunoblot analysis of MsrB2 in mouse tissues.
MsrB2 expression was analyzed in C57BL/6 mouse kidney (K), liver (L),
heart (H), and brain (B) by western blot using antibodies specific for
mouse MsrB2. Migration of MsrB2 is shown by an arrow, molecular
weight markers are shown on the right, and the control for protein
loading (b-Actin) is also shown.
doi:10.1371/journal.pone.0011497.g008
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larger forms. Interestingly, disruption of CxxC motifs that
coordinated a structural zinc atom decreased the levels of both
full length and short forms. Site-specific proteolysis may be used to
both activate and inactivate enzymes [33,34]. To examine how the
cleavage affects MsrB1 activity, we engineered a factor Xa
cleavage site at the predicted cleavage site within MsrB1. The
recombinant protein exhibited activity, which was lost upon
treatment of MsrB1 with factor Xa. While these data may be
interpreted in support of protein inactivation by proteolytic
cleavage, the artificial nature of the factor Xa site does not allow
us to make this conclusion without further verification. We also
examined the role of oxidative stress in regulating the expression of
the 5 kDa MsrB1 form. Hydrogen peroxide treatment of HEK
293 cells expressing MsrB1 did not affect the abundance of the
5 kDa form. Finally, we tested whether the generation of two
protein forms is common to other MsrBs. Only one protein form
was detected in the case of MsrB2, a mammalian mitochondrial
MsrB. Thus, the production of abundant 5 and 14 kDa forms is
not a general feature of mammalian MsrBs.
In summary, we described the process of intronization in a
subset of rodents that led to evolution of a new mRNA form of
MsrB1. This form was as efficient as the ancestral form in MsrB1
protein synthesis and in Sec insertion. The evolved MsrB1 mRNA
form was the major form in C57BL/6 mice. Each of the MsrB1
mRNA forms could generate two protein forms of MsrB1,
apparently due to proteolytic cleavage of the enzyme. We
examined this process in detail, which excluded several common
mechanisms responsible for generation of protein isoforms.
However, further studies are needed to determine the specific
function of the 5 kDa fragment of MsrB1.
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